Solesence, Inc. SLSN R2K

Q: What is the current share price of Solesence, Inc. (SLSN)?

As of 2026-07-14 21:23 PDT, Solesence, Inc. (SLSN) trades at $0.64 on NasdaqCM. Its 52-week range is $0.64 to $4.48.

Q: What is the market capitalisation of SLSN?

Solesence, Inc. (SLSN) has a market capitalisation of $45.20M on NasdaqCM.

Q: What is the P/E ratio of SLSN?

SLSN trades at a trailing price-to-earnings (P/E) ratio of 64.00. The industry average P/E is 20.95. Its price-to-book (P/B) ratio is 5.32.

Q: What is the return on equity (ROE) of SLSN?

SLSN has a return on equity (ROE) of 5.88%. Its return on capital employed (ROCE) is 4.35%.

Q: Is SLSN a good stock to buy?

This page provides a data-driven analysis of Solesence, Inc. (SLSN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Consumer Defensive · Household & Personal Products · United States

https://solesence.com

Company Profile ↓

$0.64

-81.97% 1Y

Mkt Cap$45.20M

P/E64.00

P/B5.32

52W High$4.48

52W Low$0.64

Book Value$0.25

EPS (TTM)$0.01

Company Overview

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 12.6% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 13.4% CAGR over the past five years.

Recent Developments

Dec 2025 Revenue of $62.06M (+18.6% YoY); net profit $1.79M.
Trailing 12 Months Year-on-year growth — revenue -11.4%, earnings -57.7%.
5-Year Trend Long-term compounding — revenue CAGR 13.4%, profit CAGR 12.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	13.36%
1 Year:	-11.40%

Compounded Profit Growth

5 Years:	12.60%
1 Year:	-57.73%

Stock Price Performance

1 Year:	-81.97%
6 Months:	-57.61%
3 Months:	-46.21%
1 Month:	-48.79%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 0% of range

$0.64 $4.48

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)28.61 · Oversold

Price Performance

1M-48.79%

3M-46.21%

6M-57.61%

1Y-81.97%

Valuation vs Sector

P/E of 64.00 is above the sector median of 20.95 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Compounding revenue at 13.4% over 5 years.
Profit CAGR of 12.6% over 5 years.

CONS

Trading at a high P/E of 64.0.
Trading 85.7% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

64.00

Industry PE

20.95

Forward P/E est.

128.00

PEG Ratio

Book Value

$0.25

Price to Book

5.32

P/S

1.56

EV/EBITDA

64.39

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

13.36%

Profit 5Y

12.60%

Revenue (YoY)

-11.40%

Earnings (YoY)

-57.73%

Profitability & Returns

ROCE

4.35%

ROE

5.88%

ROA

0.97%

Profit Margin

1.56%

Op Margin

-3.89%

Gross Margin

26.52%

EPS (Latest Qtr)

$-0.01

EPS (TTM)

$0.01

Balance Sheet & Liquidity

Debt/Equity

1.31

Quick Ratio

0.55

Current Ratio

2.08

Debt

$22.28M

Total Assets

$47.79M

Current Assets

Working Capital

Ownership

Promoter Holding

73.11%

Chg in Prom Hold

FII / Inst Holding

6.29%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

$45.20M

Total Revenue (TTM)

$60.40M

EBITDA

$1.80M

Free Cash Flow

$-3.87M

Operating Cash Flow

$171.00K

Shares Outstanding

70.63M

Gross Margin

26.52%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SLSN Solesence, Inc. R2K	0.64	64.00	$45.20M	0.00%	4.35%	5.88%	13.36%	12.60%
2	WMT Walmart Inc. SPX	113.70	40.04	$904.83B	0.89%	18.21%	24.13%	5.27%	23.30%
3	COST Costco Wholesale Corporation NDXSPX	921.75	46.46	$408.78B	0.60%	25.96%	29.15%	8.16%	11.45%
4	KO The Coca-Cola Company SPX	83.08	26.13	$357.45B	2.57%	16.47%	43.37%	2.86%	4.46%
5	PG The Procter & Gamble Company SPX	146.08	21.36	$340.16B	2.85%	22.93%	31.11%	0.36%	1.66%
6	PM Philip Morris International Inc. SPX	175.95	24.78	$274.23B	3.19%	34.03%	-113.55%	-1.69%	3.57%
7	PEP PepsiCo, Inc. NDXSPX	135.45	21.23	$185.13B	4.10%	15.41%	43.88%	4.93%	2.11%
8	MO Altria Group, Inc. SPX	70.16	14.65	$117.16B	5.89%	38.27%	-	1.24%	-1.89%
9	MNST Monster Beverage Corporation NDXSPX	98.00	47.34	$95.84B	0.00%	28.33%	26.65%	13.03%	14.82%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Mar 2013	Jun 2013	Sep 2013	Mar 2014	Jun 2014	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Mar 2017	Jun 2017	Sep 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.02M	3.75M	3.29M	3.07M	4.04M	4.33M	3.89M	7.07M	7.11M	7.92M	8.16M	11.22M	9.68M	9.46M	11.87M	7.96M	9.87M	13.05M	16.87M	14.62M	20.36M	14.60M	12.96M
Gross Profit	906.00K	849.00K	516.00K	708.00K	1.03M	796.00K	565.00K	992.00K	883.00K	456.00K	1.51M	680.00K	1.20M	1.20M	585.00K	410.00K	1.41M	1.06M	884.00K	832.00K	563.00K	1.03M	1.71M	1.69M	2.03M	2.51M	2.98M	2.17M	2.74M	2.49M	2.15M	3.67M	1.53M	3.58M	3.74M	6.10M	3.38M	5.88M	3.37M	3.34M
Operating Income	-483.00K	-461.00K	-632.00K	-427.00K	-69.00K	-348.00K	-603.00K	-90.00K	-151.00K	-606.00K	466.00K	-422.00K	57.00K	28.00K	-634.00K	-913.00K	97.00K	-124.00K	-470.00K	-597.00K	-815.00K	-43.00K	654.00K	552.00K	497.00K	960.00K	1.40M	105.00K	123.00K	-634.00K	-1.00M	579.00K	-1.22M	1.11M	1.05M	3.20M	256.00K	1.91M	-781.00K	-504.00K
Net Income	-484.00K	-452.00K	-633.00K	-429.00K	-70.00K	-349.00K	-606.00K	-93.00K	-155.00K	-610.00K	463.00K	-425.00K	46.00K	22.00K	-643.00K	-924.00K	88.00K	-136.00K	-513.00K	-647.00K	-862.00K	-167.00K	532.00K	430.00K	1.31M	41.00K	1.36M	62.00K	50.00K	-750.00K	-1.16M	333.00K	-1.44M	893.00K	856.00K	3.04M	80.00K	2.67M	-1.12M	-766.00K
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-0.02	-	0.00	0.00	-	-0.02	-0.02	0.00	0.01	0.01	0.03	0.00	0.03	0.00	0.00	-0.02	-0.02	0.01	-0.03	0.02	0.01	0.04	0.00	0.04	-0.02	-0.01
R&D Expense	429.00K	453.00K	375.00K	337.00K	336.00K	316.00K	302.00K	343.00K	325.00K	301.00K	372.00K	386.00K	384.00K	476.00K	494.00K	558.00K	538.00K	416.00K	477.00K	485.00K	488.00K	372.00K	357.00K	405.00K	499.00K	536.00K	635.00K	666.00K	797.00K	848.00K	1.00M	991.00K	1.06M	910.00K	864.00K	970.00K	1.02M	955.00K	1.08M	1.04M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	9.46M	9.65M	10.04M	9.59M	9.94M	10.31M	10.78M	12.47M	14.19M	12.51M	17.12M	29.48M	37.32M	37.30M	52.35M	62.06M
Gross Profit	2.53M	2.33M	2.64M	2.56M	2.83M	3.11M	3.24M	3.85M	3.29M	2.62M	5.99M	8.69M	8.36M	7.83M	16.19M	16.06M
Operating Income	-4.10M	-3.36M	-2.39M	-2.49M	-1.72M	-1.18M	-1.27M	-772.00K	-2.02M	-2.80M	1.49M	2.56M	-2.26M	-3.55M	5.13M	1.57M
Net Income	-4.08M	-3.36M	-2.39M	-2.48M	-1.73M	-1.19M	-1.28M	-789.00K	-2.08M	-3.01M	989.00K	2.32M	-2.62M	-4.39M	4.24M	1.79M
Diluted EPS	-	-	-	-	-	-	-	-	-	-0.08	0.03	0.05	-0.05	-0.09	0.07	0.02
R&D Expense	1.61M	1.74M	1.63M	1.68M	1.34M	1.27M	1.55M	1.74M	2.06M	1.87M	1.57M	2.23M	3.04M	3.84M	3.84M	4.09M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	13.48M	9.09M	9.65M	7.03M	5.73M	4.57M	4.84M	6.27M	6.57M	9.37M	13.54M	28.39M	33.56M	32.88M	50.00M	50.05M
Total Equity	14.09M	10.44M	7.48M	7.60M	5.37M	3.85M	2.86M	2.79M	3.23M	1.38M	1.51M	2.73M	7.46M	5.65M	1.90M	14.95M	17.63M
Cash & Equivalents	3.90M	5.74M	2.69M	4.12M	3.28M	1.86M	1.27M	1.78M	1.96M	1.34M	1.19M	957.00K	657.00K	2.19M	1.72M	1.41M	1.29M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	952.00K	1.00M	1.00M	-	-	-
Current Liabilities	-	2.26M	819.23K	1.20M	857.00K	976.00K	878.00K	1.30M	2.02M	3.64M	4.41M	6.78M	7.34M	13.84M	15.59M	25.77M	13.93M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-1.45M	-2.92M	-599.50K	-	-	-	-241.00K	-960.00K	-1.34M	-2.78M	-2.06M	2.32M	-1.65M	-2.01M	1.97M	-8.57M
Investing Cash Flow	3.30M	-138.43K	-167.24K	-	-	-	-165.00K	-72.00K	-160.00K	-740.00K	-878.00K	-1.87M	-2.82M	-1.05M	-4.56M	-2.14M
Financing Cash Flow	-8.47K	3.33K	2.20M	-	-	-	910.00K	1.21M	892.00K	3.37M	2.70M	-747.00K	6.00M	2.59M	2.27M	10.59M
Capital Expenditure	-253.45K	-85.99K	-152.00K	-279.00K	-216.00K	-280.00K	-128.00K	-209.00K	-160.00K	-740.00K	-878.00K	-1.87M	-2.82M	-1.05M	-4.56M	-
Free Cash Flow	-1.70M	-3.00M	-751.50K	-	-	-	-369.00K	-1.17M	-1.50M	-3.52M	-2.94M	447.00K	-4.47M	-3.06M	-2.59M	-

Ratios (Annual)

Figures in %.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	26.7%	24.1%	26.3%	26.7%	28.5%	30.2%	30.0%	30.9%	23.2%	20.9%	35.0%	29.5%	22.4%	21.0%	30.9%	25.9%
Operating Margin %	-43.3%	-34.9%	-23.8%	-26.0%	-17.3%	-11.4%	-11.8%	-6.2%	-14.3%	-22.4%	8.7%	8.7%	-6.1%	-9.5%	9.8%	2.5%
Net Margin %	-43.1%	-34.9%	-23.8%	-25.8%	-17.4%	-11.6%	-11.9%	-6.3%	-14.7%	-24.0%	5.8%	7.9%	-7.0%	-11.8%	8.1%	2.9%
ROE %	-39.0%	-45.0%	-31.5%	-46.2%	-44.9%	-41.7%	-46.0%	-24.4%	-150.4%	-198.9%	36.2%	31.1%	-46.4%	-230.8%	28.3%	10.2%
ROCE %	-36.5%	-40.7%	-28.3%	-40.4%	-36.2%	-31.9%	-35.8%	-18.2%	-69.0%	-56.3%	22.0%	12.2%	-11.4%	-20.5%	21.2%	4.4%

Shareholding Pattern

Insiders

73.11%

Institutions

6.29%

Public Float

23.41%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	1.53%	1.07M	$783.50K
2	Vanguard Capital Management LLC	1.16%	811.71K	$595.07K
3	Geode Capital Management, LLC	0.64%	451.53K	$331.01K
4	State Street Corporation	0.58%	408.99K	$299.83K
5	Morgan Stanley	0.28%	194.78K	$142.79K
6	Northern Trust Corporation	0.20%	137.51K	$100.81K
7	Vanguard Fiduciary Trust Co	0.18%	123.01K	$90.17K
8	Vanguard Portfolio Management LLC	0.16%	112.41K	$82.41K
9	Charles Schwab Investment Management, Inc.	0.07%	47.39K	$34.74K
10	Bank Of New York Mellon Corporation	0.06%	44.07K	$32.31K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SLSN

Google News ue, 07 Jul 2026

Price to sales forward of Solesence, Inc. – NASDAQ:SLSN - TradingView

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPZ3pNVHlRWTlPLXMwSGgzT1hVUjh3bFA4cDU5WTctem5WdUxvNWlabDNnN2kzekt2Z3ZScEI1WUpVV2FRQW90WHI2MGdRVnRvTTVZTUR2SXFXamlSNkhBeGxWbElfUDdDWkx3MDFoRXhjYjl6cVA3alVHTUxDako0M3ZUejBFNUJpWUxKTU…

Google News Mon, 13 Jul 2026

SLSN Q1 2026 Earnings: Pre-Revenue Losses and Stock Decline - Management Tone Analysis - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQTUxMZThVYmxvU0oyX1V4by1mdlhYNjJuVFZyTW02QUpDUnZfV0Zrc1FvOTlvOVZHemwxUk1na2N3eXlaSG1qU3dZdzFFWEF5SWx2NlZEY3FsTHZOSk9xeUhpXzJoUGxpRDlGTkwwVnZmYXptcFpvWGM0d1U2NzJkMVYxa3NYR0JBLU43U3…

Google News Mon, 29 Jun 2026

Solesence, Inc.(NasdaqCM: SLSN) dropped from Russell 3000E Index - marketscreener.com

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOU29PcEN2aHBDZzVib0lOd0YxWWo4MmpaNENQTkdCVWhMMnZLQmNRaTRpQjBmZG1kU0lMR0szNHRrTVg2SWJLTUlGSmtER2t4NUZSYWpKWlVrOXRadXVwcUdpVzFLZWF2NlQ4aS1GSkV2a2N1cVRPRHJZMWV1QldWTjBWNmV3UWtoNGVTTn…

Google News ue, 12 May 2026

Earnings call transcript: Solesence Q1 2026 sees revenue dip, stock falls - Investing.com

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNTUdiakV6Ymx0NGo5YTl2V3dDR3Q5VVZ1R0VmN0ZCQW1jUXQ5a2VQWVpTYTJTRWZaSmRHX0pDMXE4MVpPVm0wdnNaYjdxVzdpZjZQa2NOTUhyWjV5RVc2Zjgxd1UwZUdreVRrQ2F1VXFYYk9QUk9DMFF6WEtqQjNmMFA3NEVlV05UNE0xS2…

Google News ue, 12 May 2026

Solésence Reports First Quarter 2026 Financial Results - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNenZhOFVZdEphMXdFaUo3THpEUGJKT2JISTFGODJaRS1ycUJTaTZNWGJGTFVadnVaaV9RRjlESGNMbWpzOV9oY2VET05Pc09xNlFaS1JlRXpyVlJRQ1FreERlbnNvZFlZV1ZMdkY2U25xZlRZQ0xjYTk1QzVYYURwSlp1Z2Q3MDFIbEk0MD…

Google News Sun, 05 Jul 2026

SLSN Q1 2026 Earnings: Loss per Share of -$0.01; Stock Declines 6.38% - Balance Sheet Strength - DonanımHaber

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQcW16Z05OYUNNcXJDTlBTbnJuOTRUUUItdV9BZjY2d2VMXzlUNnJ3SGdqaGlNMkR5cG9vN1BzTURoU2lTazAtY3RfTjYycDhfdTVxWHZ3alRscHJ4WlRMNlh3bmx1RVAtcWVJVF92TXFFNG5fUy02bjZZS3hXUmNsLVFMVmdaU01JZjVKMW…

SLSN — Frequently Asked Questions

What is the current share price of Solesence, Inc. (SLSN)?

As of 2026-07-14 21:23 PDT, Solesence, Inc. (SLSN) trades at $0.64 on NasdaqCM. Its 52-week range is $0.64 to $4.48.

What is the market capitalisation of SLSN?

Solesence, Inc. (SLSN) has a market capitalisation of $45.20M on NasdaqCM.

What is the P/E ratio of SLSN?

SLSN trades at a trailing price-to-earnings (P/E) ratio of 64.00. The industry average P/E is 20.95. Its price-to-book (P/B) ratio is 5.32.

What is the return on equity (ROE) of SLSN?

SLSN has a return on equity (ROE) of 5.88%. Its return on capital employed (ROCE) is 4.35%.

Is SLSN a good stock to buy?

This page provides a data-driven analysis of Solesence, Inc. (SLSN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Solesence, Inc. SLSN R2K

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Price to sales forward of Solesence, Inc. – NASDAQ:SLSN - TradingView

SLSN Q1 2026 Earnings: Pre-Revenue Losses and Stock Decline - Management Tone Analysis - dars.gov.et

Solesence, Inc.(NasdaqCM: SLSN) dropped from Russell 3000E Index - marketscreener.com

Earnings call transcript: Solesence Q1 2026 sees revenue dip, stock falls - Investing.com

Solésence Reports First Quarter 2026 Financial Results - Yahoo Finance

SLSN Q1 2026 Earnings: Loss per Share of -$0.01; Stock Declines 6.38% - Balance Sheet Strength - DonanımHaber

SLSN — Frequently Asked Questions

What is the current share price of Solesence, Inc. (SLSN)?

What is the market capitalisation of SLSN?

What is the P/E ratio of SLSN?

What is the return on equity (ROE) of SLSN?

Is SLSN a good stock to buy?

Explore More